17 results
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Pneumonia - Clinical ... pattern, irregular lines ... Pneumonia Treatment ... #BOOP #pulmonary ... ILD #diagnosis #management
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Illness Script PATHOPHYSIOLOGY ... DIAGNOSTICS: Clinical ... , neoplastic) TREATMENT ... TylerLarsenMD #COP ... #pulmonary
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... chronic obstructive pulmonary ... disease (COPD). ... are approved for clinical ... #Management #AdvancedCOPD
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... ventilated • CXR, Lung ... of AECOPD: • Clinical ... #Exacerbation #treatment ... #pulmonary
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
and density of B lines ... are co-relate with ... Helps with management ... #clinical #lung ... #ultrasound #pulmonary
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Abscess Pathophysiology ... Lung Abscess - Clinical ... Abscess Management ... #Abscess #pulmonary
General schema for respiratory support in patients with COVID-19
Low flow nasal cannula
 • Typically set at
patients with COVID ... filter • N95 mask ... Proning is a front-line ... Internet Book of Critical ... #management #schema
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... eosinophilic pneumonia, organizing ... LDH • ↑ ESR, CRP ... macrophages Treatment ... #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... cough Pleuritic CP ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... characteristic features Clinical ... cough Pleuritic CP ... TB #Diagnosis #Management ... #Treatment #ActiveTB